Skip to contentI
ICU Medical Inc
I
ICUIICU Medical Inc Q2 2024 · 10-Q
Revenue$596.46M$596.46M+8.6% vs Q2 2023 Net Income-$21.41M-$21.41MN/M vs Q2 2023 EPS Diluted-$0.88-$0.88N/M vs Q2 2023 Gross Profit$207,428,000+7.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ICU Medical Inc · CIK 883984 · Engraved from SEC EDGAR
Operating Cash Flowderived$81,953,000N/M Free Cash Flowderived$62,486,000N/M Margins · derivedGross margin34.8%−0.2 pt vs Q2 2023
Operating margin1.3%+0.8 pt vs Q2 2023
Net margin-3.6%−1.8 pt vs Q2 2023
ended Jun 30, 2024 · filed Aug 7, 2024 · 38 d after period end